Joseph Tucker

New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program

Joseph Tucker Recent News

Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
Enveric Biosciences (NASDAQ: ENVB) announced the development of an improved formulation of EB-373 designed to enhance the drug product’s scalability, stability, and delivery for ongoing preclinical studies and planned clinical development.
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent application pertaining to its EVM301 series of molecules being developed as potential treatments for mental health dis
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
Enveric Biosciences, Inc.
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
Enveric Biosciences, Inc. (NASDAQ: ENVB) has announced new research results detailing the development of novel psilocin prodrug derivatives targeting treatment of mental health disorders. A manuscript describing the research has been submitted for peer-reviewed publication and is currently
Enveric Bio Stock Spikes 115% After Its Novel Prodrug Of Psilocin Receives Notice Of Allowance From US Patent And Trademark Office
Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th
Enveric Biosciences Reports Q1 2023 Loss, Implements Deep Staff Cuts & Halting Spinoff
Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023.
EXCLUSIVE: In Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental health conditions and how clinical dat
Cannabis For Arthritis: Enveric Biosciences Files Patent On CBD Medication For Osteoarthritis
Psychedelics and cannabinoid neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of two new molecular conjugates for osteoarthritis and other pain indications, which mix CBD with Celecoxib, a generic drug commonly prescribed for osteoarthritis.
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
Texas NORML Director Hired To Oversee State Policy Reform Efforts The National Organization for the Reform of Marijuana Laws (NORML) recently announced that it has tapped Jax Finkel James to its national staff.
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
The psychedelics sector has closed one of its largest M&As since its inception.
Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries
CBD-focused biotechnology company Enveric Biosciences (NASDAQ: ENVB) confirmed Monday it will acquire psychedelics company MagicMed Industries in an all-stock deal.
Video: Experts Discuss Use of Psychedelics in Mental Health Settings
The psychedelics industry has started to gain serious traction and is attracting lots of attention these days. However, what many people may not know is that the sector has been up and running for decades, with various psychedelic substances already being used for medical treatment.
4 Psychedelics Experts On Adoption In Mainstream Medicine: 'A Mental Health Revolution'
The use of psychedelics for medical treatment is achieving a new sense of gravitas, according to the guest panelists at Benzinga's latest Cannabis Capital Conference.